Kundong Zhang
- Molecular Biology top 10%
- Cancer Research top 2%
- Immunology top 10%
- Oncology top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- Zhengjun QiuChen HuangJun CaoXiaofeng WangGuangtao LuoTao JiangLiping SuBingya Liu
- Topics
- MicroRNA in disease regulation (6 papers)RNA modifications and cancer (4 papers)Circular RNAs in diseases (4 papers)
In The Last Decade
Kundong Zhang
19 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Molecular Biology 1.0k
- Cancer Research 767
- Immunology 352
- Oncology 292
- Pulmonary and Respiratory Medicine 122
Countries citing papers authored by Kundong Zhang
This map shows the geographic impact of Kundong Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kundong Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kundong Zhang more than expected).
Fields of papers citing papers by Kundong Zhang
This network shows the impact of papers produced by Kundong Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kundong Zhang. The network helps show where Kundong Zhang may publish in the future.
Co-authorship network of co-authors of Kundong Zhang
This figure shows the co-authorship network connecting the top 25 collaborators of Kundong Zhang. A scholar is included among the top collaborators of Kundong Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kundong Zhang. Kundong Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 19 | |
| 4 | 16 | |
| 5 | 17 | |
| 6 | 22 | |
| 7 | 75 | |
| 8 | 6 | |
| 9 | Long intergenic non-coding RNA (lincRNA)-01317 suppresses human gastric cancer growth by inhibiting migration and invasion of cancer cells. | 2 |
| 10 | 223 | |
| 11 | 144 | |
| 12 | Hypoxic Tumor-Derived Exosomal miR-301a Mediates M2 Macrophage Polarization via PTEN/PI3Kγ to Promote Pancreatic Cancer Metastasisbreakdown → | 580 |
| 13 | 22 | |
| 14 | 13 | |
| 15 | Downregulation of miR-301a-3p sensitizes pancreatic cancer cells to gemcitabine treatment via PTEN. | 47 |
| 16 | 10 | |
| 17 | 20 | |
| 18 | 36 | |
| 19 | 74 | |
| 20 | 16 |
About Kundong Zhang
Kundong Zhang is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 20 papers that have together received 1.3k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), RNA modifications and cancer (4 papers) and Circular RNAs in diseases (4 papers). The work is most often cited by research in Cancer Research (767 citations), Immunology (352 citations) and Molecular Biology (1.0k citations). Kundong Zhang has collaborated with scholars based in China and Thailand. Frequent co-authors include Zhengjun Qiu, Chen Huang, Jun Cao, Xiaofeng Wang, Guangtao Luo, Tao Jiang, Liping Su, Bingya Liu, Yuhan Yang and Zengya Guo. Their work appears in journals such as PLoS ONE, Cancer Research and Experimental Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.